RE:RE:RE:The 88/12 rule
tson, again another silly attack on this board when you posted this:
<<Weren't all of the patients in the trial deemed non-responsive to BCG????? How can you or the panel then question wheter it was MCNA or BCG that was providing the benefit? The whole point of the trial and the BLA is to help people that are non-responsive to BCG.>>
it wasn't me questioning that it was the panel and in fact the FDA questioning whether the effect was due to MCNA...i believe one question was related to "BCG priming MCNA" and FYI one of the members stated i believe that he only attributed 3 responses in 93 patients as unequivacable MCNA responses, this was/is a question, whether we believe or not.